Physician profile
Tracy L Brown
NPI 1962672865
$6,406.28
in general payments reported to CMS, 2019-2025
30 companies · $3,017 in 2025
The $3,017 reported for 2025 was more than what 99% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $690 · 2022: $722 · 2023: $1,353 · 2024: $625 · 2025: $3,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,904 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,904.41 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,090.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $2,090.00 | 2025 | Nexplanon |
| Amgen INC. | $858.09 | 2021-2025 | Prolia, Repatha, Evenity |
| Novo Nordisk INC | $465.52 | 2021-2024 | Wegovy |
| Mayne Pharma Commercial LLC | $306.49 | 2022-2025 | |
| Abbvie INC. | $303.79 | 2021-2025 | |
| Boston Scientific Corporation | $226.04 | 2023 | Watchman Flx, Watchman Access System |
| Alexion Pharmaceuticals, INC. | $210.82 | 2023-2025 | Ultomiris |
| Astrazeneca Pharmaceuticals Lp | $209.98 | 2021-2023 | Lokelma |
| Exact Sciences Corporation | $174.14 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $161.57 | 2022-2024 | |
| Xeris Pharmaceuticals, INC. | $134.99 | 2023 | Gvoke Hypopen |
| Alnylam Pharmaceuticals INC. | $122.11 | 2023 | Givlaari |
| Biohaven Pharmaceuticals, INC. | $119.64 | 2021 | |
| Neurelis, INC. | $110.01 | 2022 | |
| Intuitive Surgical, INC. | $105.79 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $102.63 | 2023 | Spravato |
| Kowa Pharmaceuticals America, INC. | $94.90 | 2025 | Zoryve |
| Biohaven Pharmaceutical Holding Company Ltd. | $88.21 | 2022 | |
| Lilly USA, LLC | $77.08 | 2022 | |
| Axsome Therapeutics, INC. | $70.92 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $70.00 | 2023 | |
| Organogenesis INC. | $57.72 | 2021 | |
| Stryker Corporation | $49.76 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $44.56 | 2024 | |
| Exeltis, USA INC. | $43.13 | 2022-2024 | Slynd |
| Vivus LLC | $41.17 | 2021-2022 | |
| Dexcom, INC. | $24.46 | 2024 | Dexcom G6 Transmitter |
| Mylan Pharmaceuticals INC. | $15.70 | 2021 | |
| Agile Therapeutics, INC. | $14.93 | 2021 | |
| Myovant Sciences INC. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.